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Stem cells in adult organs reside in specialised niches that regulate their proliferation and 
differentiation. Investigations during the last few years have unveiled a regulatory role for blood 
vessels in these microenvironments. Mesenchymal stem cells are located surrounding capillaries 
in a variety of tissues and have the capacity to differentiate into different mesodermal lineages. 
Angiogenic progenitor cells have also been found in the adventitial layer of large vessels. In the 
bone marrow, endothelial cells control hematopoietic stem cell release and in the brain blood 
vessels regulate neural stem cell self-renewal and neurogenesis. Similarly, perivascular 
progenitor cells have also been found in the heart. This intimate connection between stem cells 
and the vasculature contributes to tissue homeostasis and repair. In this review we focus on the 
regulation of stem and progenitor cells in different adult niches by blood vessels and the few 
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For centuries blood vessels have been defined as conduits that distribute oxygen and nutrients to 
all tissues in the body. Recently however, the vasculature has been suggested to play a role in 
tissue homeostasis and repair that goes beyond its traditional blood carrier function and involves 
hosting and regulation of stem and progenitor cells. Adult stem cells reside in specialized niches 
that provide an ideal microenvironment for the maintenance of their properties (Fig. 1). In these 
niches, stem cells are often found in the proximity of blood vessels, suggesting a role for the 
niche vasculature in supporting stem cell function [1-5]. However the precise role of blood 
vessels in the regulation of stem cell self-renewal and differentiation and the contribution of the 
perivascular niche to tissue homeostasis and repair is far from being well understood. Here we 
summarize recent advances in our knowledge of the vascular stem cell niche in adult mammalian 
organisms. 
 
Pericytes and Mesenchymal Stem Cells 
Throughout the body different types of progenitor cells accumulate around blood vessels. 
Capillaries, arterioles and venules are covered by pericytes in a discontinuous manner at a ratio 
of 1-10 endothelial cells for each pericyte, depending on the tissue [6]. Pericytes are located 
within the basement membrane and in direct contact with endothelial cells. They are distributed 
along microvessels and don’t seem to occupy a particular microenvironment in the tissue. 
Although their exact function is not completely understood, they’re thought to regulate 
endothelial cell proliferation, permeability and integrity. Because there is no unique marker for 
pericytes, these cells are defined by their ultrastructural characteristics and by the expression, 
among other markers, of the proteoglycan NG2 and the receptor for platelet-derived growth 
factor  (PDGF-) [6]. PDGF- is one the main mediators of endothelium-pericyte 
communication. It is necessary for pericyte recruitment by endothelial cells not only during 
development but also in disease. Blockade of PDGF- after myocardial infarction impairs 
pericyte recruitment by capillaries in the injured area, prevents vessel maturation, prolongs 
inflammation and interferes with extracellular matrix deposition in the infarct region [7]. 
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Similarly, PDGF- mediates the recruitment of pericytes from the epicardium to cover new 
vessels in the regenerating zebrafish heart [8]. 
In addition to their supportive role for endothelial cells, pericytes have been suggested to 
contribute to tissue homeostasis as progenitor cells [9]. Pericytes from different organs can 
differentiate into a variety of mesoderm-derived cell types, such as osteoblasts, skeletal 
myocytes, SMCs, adipocytes and others [6,9,10]. This plasticity has led to the suggestion that 
pericytes are mesenchymal stem cells (MSCs) [9]. Although both cell types share some markers 
and differentiation potential, whether they actually represent the same cell type, whether MSCs 
represent a pericyte subpopulation or whether they can give rise to each other is currently under 
debate [6,11,12]. 
MSCs were originally described in the bone marrow stroma as fibroblast-like cells 
(colony-forming unit fibroblast, CFU-F) with the capacity to acquire osteoblast, chondrocyte and 
adipocyte phenotypes [12,13]. Bone marrow MSCs (BM-MSCs) were subsequently identified in 
other organs and the term MSCs was generalized to refer to stem cells with a mesenchymal 
phenotype that can differentiate into a number of mesodermal tissues, including muscle, fat and 
bone. The perivascular location of MSCs was noted initially in the bone marrow and then 
confirmed in other tissues [14]. Unfortunately, the lack of a unique MSC marker has obfuscated 
the investigation of the origin and true differentiation potential of these cells. Although MSCs 
are often referred to as a single cell type, it is likely that it comprises a heterogeneous population 
of cells with diverse differentiation potential [12]. The intermediate filament Nestin has recently 
been shown to be a reliable BM-MSC marker [15], but it remains to be seen whether MSCs from 
other tissues can be discriminated using this protein, which also marks other mesenchymal 
tissues and neural progenitors. 
One of the most attractive features of MSCs is their ability to differentiate into a range of 
cell types regardless of their tissue of origin [9,11]. The ease of isolation of MSCs together with 
their plasticity makes them ideal for regenerative therapies for diverse organs, including the 
infarcted heart. Initial studies showed that injection of bone marrow cells after myocardial 
infarction, including MSCs but only a few hematopoietic cells, improve cardiac function [16,17]. 
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Recent clinical trials with purified bone marrow-derived MSCs have proven the safety of the 
treatment, showing functional improvement and reduced remodelling in some patients [18-20]. 
The exact cellular contribution of MSCs to the heart – if any – is difficult to determine 
accurately, mainly due to the lack of specific markers. Only a small proportion of the injected 
MSCs has been reported to transdifferentiate into cardiomyocytes or endothelial cells [21,22] 
and it is now generally accepted that they provide beneficial effects mainly through paracrine 
mechanisms [20]. Besides secreting growth factors and extracellular matrix remodelling proteins, 
MSCs, at least those isolated from the bone marrow, have anti-inflammatory properties that 
contribute to their therapeutic potential [23]. Modulation of inflammation may be partially 
responsible for the beneficial effects observed after MSC injection into injured tissues, which 
would allow activation of endogenous repair mechanisms. As discussed below, perivascular 
MSCs are not only thought to be regulated by blood vessels in the stem cell niche but they also 
play a regulatory role themselves.  
 
The adventitial niche 
The traditional view of the tunica adventitia as a passive layer with a mere support role has been 
challenged in recent years [24]. The adventitia controls the exchange of endothelial and SMCs 
with the surrounding tissue and the formation of vessels that nourish these two layers [24]. It also 
regulates the remodelling of the vessel wall, smooth muscle contraction and hosts a number of 
leukocyte populations ready to fight a possible infection. Interestingly, a number of progenitor 
cell populations have been identified in this layer that argues for a niche role of the adventitia of 
large vessels [11,24,25]. These cells are different from pericytes and MSCs but can differentiate 
into the latter in vitro [11]. They mainly give rise to endothelial or smooth muscle cells and 




 progenitor cells with vasculogenic capacity 
have been described in the adventitia [26-28]. Some of these can give rise to multipotent cells in 







 cells in the human fetal aorta can generate both endothelial and mural 
cells [30].  A similar CD34
+
 progenitor population was identified in the vasa vasorum of the 
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MSCs, are clonogenic and can be induced to differentiate into different mesodermal phenotypes 
[31]. Injection of these cells into the infarcted heart reduces remodelling and improves cardiac 
function [32]. Cells maintain their original phenotype after engraftment into the damaged heart 
and activate an endogenous angiogenic response by secreting miR-132 and growth factors. 
Whether the microvessels of the vasa vasorum constitute a vascular stem/progenitor cell niche is 
an intriguing possibility that deserves further study [24]. 









 cells appear in the aorta and other large vessels 
during embryonic development in response to sonic hedgehog (Shh) signalling [33]. These cells 
can differentiate into SMC-like cells and contribute to embryonic and postnatal growth of the 
vascular wall. In addition, they also play a role in pathological vascular remodelling in ApoE 
knockout mice, in which these cells are very abundant. In this model, SCA1
+
 cells 
transdifferentiate into SMCs in response to PDGF- and contribute to atherosclerosis [34]. In 




 cells has been recently identified in the adventitia of the 
aorta [35]. These rare cells have hematopoietic potential and mainly give rise to monocytes and 
macrophages, thus representing a source of inflammatory cells. Finally, a role for adventitial 
SCA1
+
 cells in tumor formation has also been suggested [24]. 
 
Hematopoietic Stem Cells 
Hematopoietic and endothelial cells are intimately associated from the embryo to adulthood 
[36,37]. The ability of blood vessels to supply stem cells is evolutionarily conserved from fish to 
mammals and may be reminiscent of embryonic development, during which haemogenic 
endothelial cells emerge from the dorsal aorta and differentiate into hematopoietic cells [38-40]. 
In the adult bone marrow, two types of niche – osteoblastic and vascular – support stem cell 
function [1,41]. Whereas the osteoblasts in the endosteum (the inner part of the bone) support 
hematopoietic stem cell (HSC) quiescence by secreting angiopoietin-1, the vascular niche 
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promotes proliferation, differentiation and migration of HSCs by providing higher concentrations 
of oxygen, nutrients and growth factors [1,41,42]. It is estimated that around 60% of HSCs are 
located around blood vessels in the bone marrow, although this figure may underestimate the 
number of HSC in contact with endosteal blood vessels [43,44]. In addition, perivascular 
hematopoietic niches have been described in other organs like the spleen [43,44] and a recent 
report showed that HSCs are generated around blood vessels in the placenta during development 
[45]. These reports suggest that the vasculature provides signals that regulate stem cell 
behaviour. The study of this communication was first addressed in vitro. Co-culture of 
progenitor cells with endothelial cells increased their capacity to repopulate the bone marrow of 
SCID mice [46]. Interestingly, exposure of HSCs to endothelial cells isolated from different 
tissues resulted in varying HSC growth and repopulating ability [47]. 
Although the bone marrow was one of the first niches described, the molecular 
mechanisms by which stem cells interact with their microenvironment are still not completely 
understood. Both paracrine effects and direct cell-cell contact have been implicated in the HSC-
endothelium communication. Endothelial cells express the Notch ligands Jagged and Delta-like 
that support long-term HSC proliferation and prevent their exhaustion [48]. Notch expression in 
HSCs is dependent on Wnt signalling and is necessary for maintenance of an undifferentiated 
state [49]. In addition, Notch-independent Wnt signalling is necessary for HSC growth and for 
their regenerative capacity [50]. Following injury, Notch promotes proliferation of short- and 
long-term progenitors and delays myeloid differentiation, although it seems to play no role once 
homeostasis is reached [51]. Notch signals have also been shown to be activated by ligands in 
osteoblastic cells [52]. These cells also interact with HSCs through N-cadherin, although the 
relevance of this interaction is controversial [53,54]. The endothelium also promotes HSC self-
renewal and differentiation through paracrine mechanisms. Activation of the Akt signalling 
pathway in endothelial cells induces the release of soluble factors like FGF2 and IGFBP2 that 
enhance HSC long-term proliferation and self-renewal. In contrast, activation of the Erk pathway 
induces different growth factors that shift the response of HSCs towards differentiation. These 
results suggest that signalling changes within the endothelial cell have a direct impact on the 
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HSC niche [55]. In this regard, endothelial cells from diabetic mice show functional alterations 
associated with reduced vascular perfusion and HSC depletion in the bone marrow [56]. 
The regulation of HSC in the bone marrow is strongly supported not just by the 
endothelium but also by perivascular MSCs. In fact, transplantation of perivascular MSCs can 
reconstitute the HSC microenvironment in a heterotopic site outside the bone marrow [57]. HSCs 
and progenitor cells are attracted to the vascular niche by SDF-1/CXCL12 through its receptor 
CXCR4 [58]. SDF-1 is produced by the endothelium and by CXCL12-abundant reticular cells 
(CARs), which are located around endothelial cells and help maintain HSC quiescence [58-60]. 
CAR cells are also found in the endosteum, suggesting that both HSC niches act 
interdependently and can not be separated. SDF-1 is also secreted by a population of perivascular 
Nestin
+
 MSCs associated with HSCs in the bone marrow parenchyma and next to the bone [15]. 
These cells are in close association with catecholaminergic nerve fibres and produce high 
amounts of SDF-1 and angiopioetin-1. Expression of these HSC homing factors in Nestin
+
 MSCs 
is downregulated by both G-CSF and 3 adrenergic receptor ligands to allow HSC mobilization. 
SDF-1 downregulation in MSCs and subsequent HSC egression from the bone marrow is 
impaired in diabetic patients and animal models of diabetes. Defective HSC mobilization by G-
CSF can be rescued by inhibition of the SDF-1/CXCR4 interaction, which may have important 
implications for diabetic patients needing autologous HSC transplantation [61]. Whether CAR 
and Nestin
+
 MSCs represent the same population is still unclear, but SDF-1-producing cells seem 
to be connected through connexin gap junctions that help collectively coordinate SDF-1 
production in the bone marrow [62]. Together with FGF4, SDF-1 also recruits megakaryocytic 
progenitors to the vascular niche to promote cell survival and platelet maturation [63]. It is 
important to note that SDF-1 expression in the HSC niche depends on the presence of 
macrophages. Mobilization of these cells from the bone marrow results in defective SDF-1 
production by MSCs and indirectly induces HSC egression [64,65]. Interestingly, it has been 
recently reported that stem cell factor (SCF/KITL) is expressed by endothelial cells and 
perivascular MSCs in the niche. Deletion of the Scf gene specifically in these cells – but not in 
HSCs, osteoblasts or hematopoietic cells – results in HSC depletion in the bone marrow, 
suggesting that SCF is an essential component of the vascular stem cell niche in this tissue [66]. 
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Neural Stem Cells 
Neural stem cells (NSCs) have the potential to generate the three main cell types that form the 
central nervous system (CNS), neurons, astrocytes and oligodendrocytes [67,68]. Although there 











. During each cell division, stem cells can divide symmetrically, giving rise to 
two identical stem cells, or undergo an asymmetric division, generating a stem cell and a cell 
committed to differentiate, either directly or after proliferation. The decision of an NSC to 
undergo one or another type of division is made in response to external cues provided by the 
cell's environment. NSCs, as with other adult stem cells, reside in a specialized 
microenvironment known as a stem cell niche [69]. Two main NSC niches have been described 
in the adult mouse brain: the subventricular zone (SVZ) and the dentate gyrus in the 
hippocampus (DG) [68,69]. Located on the lateral wall of the lateral ventricles, the SVZ is 
composed of different cell populations, including a monolayer of ependymal cells that lines the 
ventricle, NSCs, transit-amplifying cells, neural progenitors (neuroblasts), astrocytes and a dense 
network of blood vessels.  
In the adult mammalian brain, NSCs are located close to the vasculature in the different 
NSC niches [70] (Fig. 2). In the DG of the hippocampus, clusters of proliferating cells are 
associated with blood vessels, suggesting a link between neurogenesis and angiogenesis [71]. In 
the SVZ, which is densely vascularized, neurogenesis is also associated with the vasculature 
[72,73]. Most proliferating cells are found adjacent or very close to the blood vessels although, in 
contrast with the DG, no proliferation of endothelial cells is observed in the SVZ [72,73]. GFAP
+
 
stem cell astrocytes and transit-amplifying progenitor cells are located in the proximity of the 
capillaries and chains of neuroblasts line along the vessels as they migrate towards the rostral 
migratory stream (RMS), although without direct contact [72,73]. Depletion of proliferating cells 
in the SVZ using the antimitotic drug AraC is followed by stem cell proliferation around the 
blood vessels and regeneration of the SVZ niche [72]. Like HSCs, neural progenitor cells are 
recruited to niche blood vessels by SDF-1 and depend on 61 integrin to interact with them 
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[73,74]. Blockade of this laminin receptor results in altered SVZ cell proliferation and 
localization [73].  
The functional effect that endothelial cells exert on NSCs can be reproduced in vitro. 
Endothelial cells, but not smooth muscle cells, induce NSC proliferation in co-culture 
experiments and prevent their differentiation [75]. In addition, co-culture with endothelial cells 
prior to differentiation enhances the neurogenic capacity of NSCs. Although these data strongly 
suggest that blood vessels have an impact on stem cell function, niche homeostasis and 
neurogenesis, the molecular mechanisms underlying such effects are not completely understood. 
Interestingly, stem and progenitor cells localized around capillaries in the SVZ niche show a 
strong expression of the receptor for the epidermal growth factor (EGFR) that is further induced 
by SDF-1 [72,74], suggesting a role for the EGF family of growth factors in the regulation of 
NSC function in vivo. EGFR expression is further induced by pigment epithelium-derived factor 
(PEDF), which is secreted by endothelial and ependymal cells and supports NSC self-renewal by 
enhancing Notch signalling [76,77]. A role for nitric oxide (NO) in the regulation of the NSC 
niche has also been proposed. NO regulates both angiogenesis and neurogenesis and can promote 
either NSC proliferation or differentiation depending on the cellular source [70]. NO plays a role 
in brain tumor development [78], although its endogenous role in SVZ homeostasis needs further 
investigation. Aspects of the communication between endothelial cells and NSCs were recently 
investigated by carrying out a comprehensive analysis of the changes in gene expression that 
endothelial cells induce on NSCs and the soluble factors that may mediate this effect. 
Betacellulin (BTC), a member of the EGF family initially described to mediate the generation of 
-cells in the pancreas [79], was found to induce NSC proliferation both in vitro and in vivo [80]. 
BTC is expressed by endothelial cells and by epithelial cells of the choroid plexus, a structure in 
the brain that contributes many components of the cerebral spinal fluid (CSF) present within the 
ventricles. Infusion of BTC leads to expansion of NSCs, transit amplifying (progenitor) cells and 
neuroblasts, and is both necessary and sufficient to induce regeneration of the NSC niche. 
Importantly, the action of BTC in the SVZ translates into increased neurogenesis both in the 
olfactory bulb and the dentate gyrus. 
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Blood vessels also support neurogenesis beyond their effects in the niche. They provide 
cues that direct neuroblast migration after they leave the SVZ and secrete growth factors that 
promote differentiation and neurogenesis [70]. Brain-derived neurotrophic factor (BDNF) 
produced by the vasculature guides migration of neural progenitors and stimulates neurogenesis 
in SVZ explants [77,81]. Similarly, in canaries it directs migration of newly generated neurons to 
the high vocal centre, where it promotes neurogenesis and angiogenesis together with VEGF 
[82]. Together, these reports highlight the regulatory role of blood vessels in the brain and 
suggest therapeutic potential for some of the factors they release. 
 
Cardiac and Skeletal Muscle Stem Cells 
For years the heart was thought to be a terminally differentiated post-mitotic organ with no 
regenerative capacity whatsoever. The mere existence of cardiac stem cells has been under 
severe scrutiny over the last few years.  Recent reports however have unveiled a certain degree 
of cardiomyocyte turnover, challenging the classical paradigm and initiating a furious debate 
[83,84]. It is beyond the scope of this review to settle such arguments; we will instead focus on 
those stem and progenitor cell populations that have been described to be localized around 
cardiac blood vessels. In this regard, a cell population termed cardiac colony-forming units – 







 cells are similar to MSCs found around blood vessels in 
the bone marrow and in many adult organs, although they do not express pericyte markers. 
cCFU-Fs originate in the embryonic epicardium and mainly give rise to mural components of the 
coronary vessels during development.  Like MSCs, cCFU-Fs have clonogenic potential, they are 
capable of long-term growth in vitro and show broad differentiation capacity. Some of these 




 cardiac progenitors that 
are found around blood vessels in the heart [86]. Cardiac mesoangioblasts have a narrower 
differentiation spectrum than cCFU-Fs and mostly give rise to cardiomyocytes. They are mainly 
localized around small vessels, although they can also be found in the aorta, and their number 
reduces with age. The cardiac vasculature also hosts a population of coronary progenitor cells. 
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 cells have the potential to generate endothelial and smooth muscle cells 
and contribute to vessel regeneration [87]. Unfortunately, the factors mediating the action of 
blood vessels on these different progenitor cells have not yet been unveiled. 
In skeletal muscle, myogenic stem cells (satellite cells) are located underneath the basal 
lamina surrounding muscle fibres and in close proximity with capillary vessels [3]. Although 
satellite cells are usually quiescent, they proliferate rapidly upon injury to regenerate the 
damaged muscle. In culture, endothelial cells stimulate satellite cell growth by secreting a variety 
of growth factors, including FGF2/bFGF, HGF, IGF-1 or VEGF among others [3]. In addition, a 
pericyte population with myogenic potential has been found both in skeletal muscle and non-
muscle tissue [9]. These cells are characterized by the expression of mesenchymal stem cells 
markers and are different from satellite cells [10]. They show strong myogenic potential and 
contribute to muscle regeneration when injected into a mouse model of muscular dystrophy (mdx 
mice). Interestingly, a similar capacity was recently demonstrated by endogenous pericytes from 
skeletal muscle using a lineage tracing system based on the expression of alkaline phosphatase 
[88]. Pericytes can naturally generate satellite cells, an ability mainly detected in the first month 
of age that is lost in the adult. Interestingly, pericyte-like cells derived in vitro from human 
pluripotent stem cells potentiate vascular and muscular regeneration and contribute to both 
tissues in a mouse model of hind limb ischemia [89]. Another stem cell population found 
physically associated with small capillaries in postnatal skeletal muscle are mesoangioblasts, 
which were originally described around the embryonic dorsal aorta [90,91]. Mesoangioblasts can 
be expanded in culture and have strong potential for the regeneration of skeletal muscle [90,92]. 
Finally, a population of myoendothelial cells was isolated from skeletal muscle [93]. These cells 
express some endothelial progenitor and myogenic markers and can differentiate into neural, 
skeletal muscle and endothelial cells. They improve skeletal muscle regeneration and show 
beneficial effects when injected into the heart after myocardial infarction [93,94]. 
 
Other Stem Cells 
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The stromal vascular fraction of the white adipose tissue represents the major source of MSCs. 
These MSCs are easily isolated and display the same differentiation potential as MSCs isolated 
from other tissues [9], which makes them an attractive candidate for regenerative therapies. In 
this regard, injection of adipose tissue MSCs in pig infarcted hearts contributes to vessel 
formation and improves cardiac function with a similar efficacy to bone marrow MSCs [95]. 
Preliminary data from a recent clinical trial also suggest beneficial effects of adipose tissue 
progenitor cells in humans [96]. Interestingly, a vascular adipose stem cell niche has recently 





 adipose stem cells (ASCs) that can give rise to mature adipocytes. [4,97]. ASCs are 
located in the mural compartment of the vessel and also express NG2, SMA and PDGFR. The 
similarity between ASC and MSC markers has led to the hypothesis that ASCs actually represent 
a subset of MSCs. Unlike MSCs, however, ASCs mainly give rise to white fat adipocytes and 
not to other tissues. Interestingly, similar adipose progenitor cells have been described in the 
skin, where they regulate follicular stem cell activation by secreting PDGF [98]. Some 
adipogenic progenitors have also been reported to derive from bone marrow myeloid cells [99]. 
These cells generate a particular adipocyte subset and accumulate in visceral fat with age. 
The existence of perivascular fat stem cells supports the proposed role of the vasculature 
in the growth of adipose tissue [100]. In line with these observations, angiogenesis inhibition 
reduces obesity and depletion of adipose vasculature results in obesity reversal [101,102]. 
Conversely, adipose progenitors can influence vessel formation by secreting different angiogenic 
factors and by enhancing the ability of endothelial progenitor cells to form new vascular 
networks [100,103]. As in other perivascular stem cell niches, it is still not completely clear how 
the ASC niche contributes to the mature tissue and the impact that this may have on obesity. 
Transplantation studies have shown that ASCs contribute to adipose tissue formation when 
injected into fat pads of lipodystrophic mice or mice fed with a high fat diet [97]. These cells 
showed no homing ability when injected intravenously and needed an adipogenic environment to 
form adipocytes, suggesting that the perivascular niche may provide specific cues for adipocyte 
differentiation.  
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 In the testis, a population of undifferentiated spermatogonia that includes spermatogonial 
stem cells is organized in niches around blood vessels, particularly at branch points where 
Leydig and other interstitial cells also accumulate. However, unlike stem cells in other niches, 
undifferentiated spermatogonia are not in direct contact with the vasculature [2]. The effect of 
blood vessels on spermatogonia is thought to be indirect and could be mediated by Leydig cells. 
These cells, whose major biological function is to produce testosterone, are adjacent to the vessel 
and have been described to originate from pericytes and other perivascular cells [104]. As in 
other organs, the factors mediating the regulation of progenitor cells by blood vessels are unclear 
but colony stimulating factor 1 (CSF1) has been identified in Leydig and myoid cells as a 
potential candidate regulating spermatogonial stem cell self-renewal [105]. 
 
Artificial Stem Cell Niches as Exploratory and Therapeutic Tools 
Lessons learnt from stem cell niches in the last few years provide an opportunity for the 
development of novel therapeutic tools for regenerative medicine. Understanding the 
contribution of the different components of the niche and in particular that of blood vessels will 
allow us to reconstruct and use artificial vascular niches (Fig. 4). Like all biological systems, 
stem cell niches are extraordinarily complex and reproduction of the microenvironmental 
conditions in a dish represents quite a challenging task [106]. First, bioengineered niches must 
include a structural support in the form of matrices or hydrogels. These must not only provide a 
scaffold for the cells but should also allow localized dynamic delivery of different growth factors 
and ligands. Cytokine delivery can be manipulated in vitro through microfluidic devices but 
presents more of a challenge if the artificial niche is to be integrated into an organism. Second, 
the niche must obviously include multipotent stem cells capable of generating adult 
differentiated tissue and support cells that provide the necessary signals for stem cell regulation. 
The relative density of each cell population should also be carefully considered, as it may have a 
strong impact on differentiation. If necessary, cells can be micropatterned into a specific 
distribution in the niche. Part of these regulatory cues could be provided by blood vessels, and 
the use of endothelial cells or vessel-derived products in these niches is beginning to be explored 
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[107,108]. Alternatively, signals from support cells could be substituted by protein-conjugated 
microbeads or by attaching cell surface ligands, like Jagged or Delta-like, to the scaffold surface 
[106]. Artificial niches must also incorporate mechanical cues that may be necessary for stem 
cell self-renewal and differentiation. These include for instance capillary shear stress or matrix 
elasticity, which can determine stem cell fate [109]. Finally, niches should be engineered in such 
a way that stem cells receive the right amount of oxygen, a major factor in stem cell self-renewal 
[110]. 
In addition to their regenerative potential, artificial niches can be used as biological 
models to study stem cell properties or individual niche components [111]. In this regard, a 
platform with various bioengineered microenvironments was recently designed to carry out high-
throughput analysis of single stem cell differentiation [112]. This system comprises several 
microwells in a polyethylene glycol hydrogel, each with different proteins and extracellular 
matrix components that influence stem cell differentiation. The platform can also integrate 
physical stimuli and allows the simultaneous evaluation of a wide variety of inputs on stem cell 
proliferation and differentiation. A complementary approach recently developed involves the use 
of in vivo artificial niches. In an interesting report, Foxn1 knockout mice were used to 
deconstruct the thymus hematopoietic microenvironment in vivo and define the role of individual 
proteins in it [113]. These mice have a defective thymic epithelial niche that impairs T cell 
development. The authors used tissue-specific transgenics to overexpress different proteins in the 
thymic epithelium of these mice, either alone or in combination, in order to identify which 
components allow reconstitution of a permissive microenvironment. The study led to the 
identification of the hierarchical role of Ccl25, Cxcl12, Scf and the Notch ligand Dll4 in the 
specification of each of the lymphocytic populations in the niche. This elegant approach could be 
also applied to the study of stem cell niches. 
 
Future Perspectives – (Long) Way to Go 
In the last few years we have made considerable progress in our understanding of adult stem 
cells and their organization in specific microenvironments. The concept of a perivascular stem 
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cell niche was unveiled in the bone marrow and then confirmed in other tissues (although 
noticeably not in all). Despite this effort, most of our knowledge of the niche is fundamentally 
descriptive and we still have a long way to go before tasting the fruits of regenerative 
bioengineering. For instance, we still lack specific markers for some of the stem cell populations, 
like MSCs, that will allow us to determine the contribution of these cells to tissue homeostasis. 
Proper markers would facilitate fate mapping studies to determine whether some or all of the 
perivascular stem cells share a common origin. Alternative splicing and proteomic analysis may 
help find new markers that specifically identify distinct stem cell populations. Importantly, 
factors mediating regulation of stem cells by blood vessels have only partially been unveiled 
(Table 1). Our ignorance of these factors may be hampering further progress in stem cell therapy, 
which might fuel the increasing disappointment sensed in the part of the scientific community 
and the society in general with this therapeutic approach. 
 Besides these issues, the role of the vascular stem cell niche itself in tissue homeostasis 
needs to be properly addressed. We need to understand the contribution of perivascular stem 
cells and the vessels themselves to tissue renewal and whether their interaction is necessary for 
the response to injury. Similarly, the biological – and therapeutical – relevance of the niche 
organization and structure needs to be evaluated. Biological deconstruction and bioartificial 
reconstruction of the stem cell microenvironment will help define the role of each of the niche 
components. In particular, we need to understand the precise role of blood vessels in the niche 
beyond their carrier function. Although many adult stem cells are localized around blood vessels 
in their niches, others aren’t. It will be necessary to investigate why the proximity of the 
vasculature is dispensable for some stem cells whereas others need to be in close contact with it.  
 Finally, although we partially understand how the stem cell niche responds to tissue 
injury, its role in repair, regeneration and disease in general needs further investigation. 
Combination of these results with the improvement of bioartifical niches will contribute to the 
advancement of stem cell therapy through more complex, structured and clinically-relevant 
therapeutic products that will finally place us in a position to translate this knowledge into 
efficient clinical therapies in the future. 
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Full characterization of the stem cell niche is needed in order to identify the cues that direct their 
differentiation and self-renewal. Understanding the microenvironmental factors that regulate 
stem cell behaviour and in particular those supplied by the endothelium will allow the generation 
of more efficient cell therapies, moving from stem cell injection to more complex treatments 
based on bioartificial stem cell niches. 
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FIGURE LEGENDS 
Figure 1. Adult stem cells are often located in the proximity of blood vessels in their niche. 
A, Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) in the bone marrow 
are close to blood vessels, which secrete SDF-1, SCF, PDGF- and Wnt to regulate their 
function. B, In the adult brain, neural stem cells (NSCs) are adjacent or in the vicinity of 
capillaries that regulate their behaviour by secreting BTC and PEDF. BV, blood vessel; LV, 
lateral ventricle; (B) NSCs; (C) transit-amplifying cells; (A) neuroblasts. C, A population of 
MSC-like cells and other progenitor cells reside close to blood vessels in the heart. The factors 
secreted by the vasculature to regulate these cells have not been unveiled yet. 
 
Figure 2. Neural stem cells are located close to blood vessels in the adult brain. Adult mouse 
brains were isolated, fixed and stained with antibodies directed against markers for different cell 
populations. NSCs were identified by strong expression of SOX2 (blue) and transit-amplifying 
progenitors were labelled with anti-Mash1 (red). Blood vessels were stained with anti-CD31 
(green). A higher magnification is shown in the right panel. LV, left ventricle; RMS, rostral 
migratory stream. Bar, 100 m. 
 




 adipose stem cells 
(ASC) are localized around blood vessels among other mural cells. ASCs can respond to high fat 
diet and generate new adipocytes. In contrast, mesenchymal stem cells (MSC) have a wider 
differentiation capacity that makes them good candidates for stem cell therapies of different 
diseases, including myocardial infarction. Blood vessels regulate ASCs through an unknown 
mechanism and conversely adipose progenitors can promote vessel formation by secreting 
VEGF and other angiogenic factors. 
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Figure 4. Integration of different regulatory stimuli into bioartificial stem cell niches. 
Artificial stem cell niches must integrate biochemical and biomechanical cues that reproduce the 
environment faced by stem cells in the niche. The bioartificial niche must obviously include 
multipotent stem cells capable of generating adult differentiated tissue. It should also contain 
support cells that provide the necessary signals for stem cell regulation. Part of these regulatory 
cues must be provided by blood vessels, although they could be substituted by protein-
conjugated microbeads or by attaching cell surface ligands to the scaffold surface. Structural 
support in the form of matrices or hydrogels will not only provide a scaffold for the cells but will 
also allow localized delivery of growth factors. Importantly, artificial niches must also 
incorporate mechanical cues and should be engineered in such a way that they deliver the right 
amount of oxygen to stem cells. 
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Table 1. Soluble growth factors released by the vasculature (endothelial cells or mural cells) 
that regulate adult stem cells in different niches. PDGF-, platelet-derived growth factor-; 
SDF-1, stromal cell-derived factor-1; SCF, stem cell factor; BDNF, brain-derived neurotrophic 
factor; PEDF, pigment epithelium-derived factor; BTC, betacellulin; FGF2, fibroblast growth 
factor 2; HGF, hepatocyte growth factor; IGF-1, insulin-like growth factor; VEGF, vascular 










Activity in the Niche Ref. 
PDGF- Mesenchymal  Regulates pericyte-endothelial cell communication 6 
SDF-1 HSC, Neuronal 
Recruitment of HSC and NSC to niche blood 
vessels 
58, 74 
SCF/KITL HSC Maintenance of HSC in bone marrow 66 
Wnt HSC Regulates HSC self-renewal and growth 49, 50 
BDNF Neuronal Guides migration and stimulates neurogenesis 77,81 
PEDF Neuronal Enhances PEDF self-renewal 76,77 
BTC Neuronal 
Stimulates  NCSs  and progenitors proliferation, 
induces neurogenesis 
80 
FGF2 Skeletal muscle Stimulates satellite cell growth 3 
HGF Skeletal muscle Stimulates satellite cell growth 3 




Stimulates satellite cell growth; induces 
neurogenesis and angiogenesis 
3, 82 
CSF-1 Spermatogonial Regulates spermatogonial stem cell self-renewal 105 
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